The way I see this going is that the feds won’t want us to be able to access information about our own genomes directly, but will want the insurance companies to have access to it. As I understand it, they only sequence certain portions of the DNA, and provide analyses. It might be a harder model for the feds to stick their fingers in if you could just get a sequence of your entire genome (pricier, but not prohibitively expensive at this point) which you could argue is simply for your information, and have someone release open source software that automatically does some of the data analysis, which would be a free speech issue if they tried to censor it. (Not that that would likely stop the FDA, but there’s a lot more legal and social leverage behind that position.)